130 related articles for article (PubMed ID: 27293554)
1. Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study.
Price RJ; Lillycrop KA; Burdge GC
J Nutr Sci; 2016; 5():e17. PubMed ID: 27293554
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation in vitro induces cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA methylation of their promoters or DNA repair.
Price RJ; Lillycrop KA; Burdge GC
Nutr Res; 2015 Jun; 35(6):532-44. PubMed ID: 25960189
[TBL] [Abstract][Full Text] [Related]
3. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
[TBL] [Abstract][Full Text] [Related]
4. Folate supplementation induces differential dose-dependent modulation of proliferative phenotypes among cancerous and noncancerous oral cell lines in vitro.
McCabe J; Chang S; Hajibandeh J; Tran MD; Meeder CA; Sharma K; Nguyen DH; Moody M; Keiserman MA; Bergman CJ; Kingsley K
J Diet Suppl; 2010 Dec; 7(4):325-40. PubMed ID: 22432562
[TBL] [Abstract][Full Text] [Related]
5. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231.
Mansara PP; Deshpande RA; Vaidya MM; Kaul-Ghanekar R
PLoS One; 2015; 10(9):e0136542. PubMed ID: 26325577
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
Miotti S; Bagnoli M; Ottone F; Tomassetti A; Colnaghi MI; Canevari S
J Cell Biochem; 1997 Jun; 65(4):479-91. PubMed ID: 9178098
[TBL] [Abstract][Full Text] [Related]
7. A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan.
Wang X; Wu X; Liang Z; Huang Y; Fenech M; Xue J
Mutagenesis; 2006 Jan; 21(1):41-7. PubMed ID: 16339195
[TBL] [Abstract][Full Text] [Related]
8. Effect of folic acid on human trophoblast health and function in vitro.
Ahmed T; Fellus I; Gaudet J; MacFarlane AJ; Fontaine-Bisson B; Bainbridge SA
Placenta; 2016 Jan; 37():7-15. PubMed ID: 26748157
[TBL] [Abstract][Full Text] [Related]
9. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.
Lin SY; Lee WR; Su YF; Hsu SP; Lin HC; Ho PY; Hou TC; Chou YP; Kuo CT; Lee WS
Angiogenesis; 2012 Dec; 15(4):671-83. PubMed ID: 22843228
[TBL] [Abstract][Full Text] [Related]
10. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
12. Folic Acid Induces Intake-Related Changes in the Mammary Tissue Transcriptome of C57BL/6 Mice.
Burton MA; Antoun E; Penailillo RS; Burdge GC; Lillycrop KA
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32942660
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults.
Obeid R; Kirsch SH; Kasoha M; Eckert R; Herrmann W
Metabolism; 2011 May; 60(5):673-80. PubMed ID: 20727555
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation in pregnancy: Are there devils in the detail?
Burdge GC; Lillycrop KA
Br J Nutr; 2012 Dec; 108(11):1924-30. PubMed ID: 23046900
[TBL] [Abstract][Full Text] [Related]
15. Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells.
Novakovic P; Stempak JM; Sohn KJ; Kim YI
Carcinogenesis; 2006 May; 27(5):916-24. PubMed ID: 16361273
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
17. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
18. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway.
Hou TC; Lin JJ; Wen HC; Chen LC; Hsu SP; Lee WS
Biochem Pharmacol; 2013 Feb; 85(3):376-84. PubMed ID: 23178654
[TBL] [Abstract][Full Text] [Related]
19. N-3 fatty acids and lipid peroxidation in breast cancer inhibition.
Stoll BA
Br J Nutr; 2002 Mar; 87(3):193-8. PubMed ID: 12064327
[TBL] [Abstract][Full Text] [Related]
20. Effects of folic acid on the antiproliferative efficiency of doxorubicin, camptothecin and methyl methanesulfonate in MCF-7 cells by mRNA endpoints.
Xavier MA; de Oliveira MT; Baranoski A; Mantovani MS
Saudi J Biol Sci; 2018 Dec; 25(8):1568-1576. PubMed ID: 30581319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
